ARKEMA financials
ARKEMA
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
9695000EHMS84KKP2785 ISIN: FR0010313833 Financial statements
(EUR, as reported — unscaled; 95 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Operating profit (EBIT) | €288.0M | €586.0M |
| Net finance income / (cost) | -€125.0M | -€73.0M |
| Income tax expense | €100.0M | €150.0M |
| Profit for the year | €62.0M | €357.0M |
| — attributable to owners | €63.0M | €354.0M |
| — attributable to NCI | -€1.0M | €3.0M |
| Total comprehensive income | -€512.0M | €509.0M |
| Per share | ||
| Basic EPS | €0.52 | €4.51 |
| Diluted EPS | €0.51 | €4.49 |
| Cash flow statement | ||
| Net cash from operating activities | €997.0M | €1.12B |
| Net cash from investing activities | -€616.0M | -€940.0M |
| Net cash from financing activities | -€286.0M | -€207.0M |
| Dividends paid | €304.0M | €279.0M |
| Net change in cash | €95.0M | -€26.0M |
| Balance sheet | ||
| Total assets | €14.24B | €15.21B |
| Non-current assets | €9.42B | €10.21B |
| Intangible assets & goodwill | €2.87B | €3.07B |
| Current assets | €4.83B | €5.00B |
| Inventories | €1.14B | €1.35B |
| Trade & other receivables | €1.19B | €1.31B |
| Cash & equivalents | €2.19B | €2.01B |
| Total equity | €7.03B | €7.76B |
| — attributable to owners | €6.84B | €7.53B |
| Non-controlling interests | €189.0M | €235.0M |
| Non-current liabilities | €4.95B | €4.96B |
| Long-term borrowings | €3.80B | €3.68B |
| Current liabilities | €2.26B | €2.49B |
| Deferred tax liabilities | €429.0M | €435.0M |
| Derived metrics | ||
| Operating margin | 3.2% | 6.1% |
| Net margin | 0.7% | 3.7% |
| Return on equity | 0.9% | 4.6% |
| Cash conversion ratio | 16.08× | 3.14× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €838.0M | €802.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€11.0M | -€1.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€1.0M | -€7.0M |
| Cancellation of Treasury Shares | €0 | €0 |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €58.0M | €132.0M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€409.0M | €334.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€2.0M | €150.0M |
| Cash Receipts From Repayment of Advances and Loans Made To Related Parties | €80.0M | €63.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | -€42.0M | -€22.0M |
| Comprehensive Income Attributable To Owners of Parent | -€470.0M | €531.0M |
| Current Accrued Expenses and Other Current Liabilities | €438.0M | €424.0M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €756.0M | €874.0M |
| Current Derivative Financial Assets | €8.0M | €20.0M |
| Current Derivative Financial Liabilities | €24.0M | €32.0M |
| Current Tax Assets Current | €100.0M | €101.0M |
| Current Tax Liabilities Current | €71.0M | €82.0M |
| Deferred Tax Assets | €151.0M | €155.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €272.0M | €261.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €3.60 | — |
| Dividends Recognised As Distributions To Owners Per Share | €3.60 | — |
| Equity and Liabilities | €14.24B | €15.21B |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €0 | €1.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €5.0M | €2.0M |
| Increase Decrease In Working Capital | -€156.0M | €87.0M |
| Increase Decrease Through Sharebased Payment Transactions | €16.0M | €40.0M |
| Increase Decrease Through Transactions With Owners | -€217.0M | -€203.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €5.0M | €11.0M |
| Inflows of Cash From Investing Activities | €108.0M | €69.0M |
| Intangible Assets Other Than Goodwill | €2.14B | €2.37B |
| Investment Accounted For Using Equity Method | €9.0M | €11.0M |
| Issue of Equity | €0 | €61.0M |
| Issued Capital | €761.0M | €761.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €33.0M | €50.0M |
| Noncurrent Provisions For Employee Benefits | €340.0M | €391.0M |
| Other Adjustments To Reconcile Profit Loss | €14.0M | €41.0M |
| Other Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | €0 | €0 |
| Other Comprehensive Income | -€574.0M | €152.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€6.0M | -€3.0M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation of Foreign Operations and Hedges of Net Investments In Foreign Operations | -€569.0M | €153.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €21.0M | €8.0M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€15.0M | -€3.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€575.0M | €149.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €1.0M | €3.0M |
| Other Current Nonfinancial Assets | €202.0M | €201.0M |
| Other Noncurrent Assets | €285.0M | €327.0M |
| Other Operating Income Expense | -€132.0M | -€155.0M |
| Outflows of Cash From Investing Activities | €724.0M | €1.01B |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €0 | €3.0M |
| Proceeds From Issue of Subordinated Liabilities | €399.0M | €399.0M |
| Proceeds From Issuing Shares | €0 | €63.0M |
| Proceeds From Noncurrent Borrowings | €505.0M | €502.0M |
| Property Plant and Equipment Including Rightofuse Assets | €3.94B | €4.23B |
| Repayments of Noncurrent Borrowings | €448.0M | €791.0M |
| Repayments of Subordinated Liabilities | €0 | €400.0M |
| Research and Development Expense | €284.0M | €278.0M |
| Reserve of Exchange Differences On Translation | -€180.0M | €348.0M |
| Revenue From Contracts With Customers | €9.07B | €9.54B |
| Selling General and Administrative Expense | €910.0M | €920.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€1.0M | -€6.0M |
| Trade and Other Current Payables To Trade Suppliers | €971.0M | €1.07B |
| Treasury Shares | €30.0M | €22.0M |
Methodology
Every line item above is a fact tagged in ARKEMA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.